World Parkinson Congress Blog

Posts in Clinical Science

The Importance of Modeling Peripheral Nervous System Dysfunction and Old Age in Parkinson’s Disease

The Importance of Modeling Peripheral Nervous System Dysfunction and Old Age in Parkinson’s Disease

by Nathalie Van Den Berge

Clinical ScienceNathalie Van Den BergeFebruary 9, 2023Parkinson's, nervous system, peripheral, Eight

What Are the Gene Therapy and Growth Factor Approaches for Parkinson’s Disease?

What Are the Gene Therapy and Growth Factor Approaches for Parkinson’s Disease?

by Krystof S. Bankiewicz, MD, PhD

Clinical ScienceKrystof S. Bankiewicz, MD, PhDFebruary 2, 2023Parkinson's Disease, Gene Therapy, Advanced Therapeutics, Growth Factors, GDNF, AAV, Neurosurgical Delivery, AskBio, Eight

Parkinson's: When Anxiety Becomes A Central Symptom Of The Disease

Parkinson's: When Anxiety Becomes A Central Symptom Of The Disease

by Kathy Dujardin, PhD

Clinical ScienceKathy Dujardin, PhDJanuary 19, 2023Parkinson's, anxiety, WPC2023, Symptoms, Eight

Radical Collaboration, Exercise, Neuroplasticity and Parkinson’s Disease

Radical Collaboration, Exercise, Neuroplasticity and Parkinson’s Disease

by Mark A. Hirsch, PhD, FACRM

Clinical ScienceMark A. Hirsch, PhDDecember 15, 2022Parkinson's, exercise, self-management, neuroplasticity, brain-derived neurotrophic factor, collaboration, wpc2023, Seven

Personalized DBS Targeting: What You Need to Know

Personalized DBS Targeting: What You Need to Know

by Vanessa Milanese, MD, PhD

Clinical ScienceVanessa Milanese, MD, PhDOctober 6, 2022Seven, Parkinson's, Deep Brain Stimulation, Quality of Life, neuromodulation, functional neurosurgery

Diagnostic Challenges and Pitfalls in Parkinson’s Disease

Diagnostic Challenges and Pitfalls in Parkinson’s Disease

by Oscar S. Gershanik, MD

Clinical ScienceOscar S. Gershanik MDJuly 25, 2022Parkinson's, Seven

How Can Aerobic Exercise Slow Down the Progression of Motor Symptoms?

How Can Aerobic Exercise Slow Down the Progression of Motor Symptoms?

by Martin E. Johansson, MSc

Clinical ScienceMartin E. Johansson, MScFebruary 23, 2022Parkinson's, MRI, aerobic exercise, longitudinal, motor progression, cognitive control, Swedish, Sweden, six

Drug Repurposing - Does It Work?

Drug Repurposing - Does It Work?

by Simon Stott, PhD

Clinical ScienceSimon Stott, PhDJanuary 6, 2022drug development, amantadine, exenatide, ambroxol, terazosin, UDCA, deferiprone, six

Prodromal PD and RBD: What Is the Link?

Prodromal PD and RBD: What Is the Link?

by Ron Postuma, MD, MSc

Clinical ScienceRon Postuma, MD, MScNovember 18, 2021Parkinson's, six

A Personal and Scientific Journey into Parkinson’s Disease: The Promise and Power of Collaboration

A Personal and Scientific Journey into Parkinson’s Disease: The Promise and Power of Collaboration

by Heidi McBride, PhD

Clinical ScienceHeidi McBride, PhDSeptember 13, 2021Parkinson's, scientists, six

The Upper Aerodigestive Tract: Control of Voice, Speech, Swallowing, and Cough

The Upper Aerodigestive Tract: Control of Voice, Speech, Swallowing, and Cough

by Corinne A. Jones, PhD, CCC-SLP

Clinical ScienceCorinne Jones, PhD, CCC-SLPApril 15, 2021Parkinson's, Upper Aerodigestive Tract, voice, speech, swallowing, cough, six

Why Participate in Clinical Trials?

Why Participate in Clinical Trials?

by Soania Mathur, MD

Clinical ScienceSoania Mathur, MDMarch 22, 2021Parkinson's, Clinical Trials, Medical Research, Patient Recruitment, six

But Wait, I’m Not Dying! Why Palliative Care Is For Living Now

But Wait, I’m Not Dying! Why Palliative Care Is For Living Now

by Janis M. Miyasaki, MD, MEd, FRCPC

Clinical ScienceJanis M. Miyasaki, MD, MEd, FRCPCMarch 8, 2021Parkinson's, Palliative Care, WPC Virtual Congress, six

Nonmotor Symptoms Treatment

Nonmotor Symptoms Treatment

by Janis M. Miyasaki, MD, MEd, FRCPC

Clinical ScienceJanis M. Miyasaki, MD, MEd, FRCPCMarch 1, 2021Parkinson's, non-motor symptoms, Apathy, Sleep, swallowing, WPC Virtual Congress, six

Infusion Therapies and other Novel Drug Delivery for Parkinson’s disease New Avenues for Old Drugs

Infusion Therapies and other Novel Drug Delivery for Parkinson’s disease New Avenues for Old Drugs

by Werner Poewe, MD

Clinical ScienceWerner Poewe, MDFebruary 8, 2021Parkinson's, Levodopa, Repurposing drugs, six

Access to Rehabilitation in Asian Countries: Time to Refine the Way to Referral?

Access to Rehabilitation in Asian Countries: Time to Refine the Way to Referral?

by Genko Oyama MD, PhD

Clinical ScienceGenko Oyama MD, PhDJanuary 25, 2021Parkinson's, rehabilitation, six

Finding Novel Strategies to Impact Everyday Life for People with Parkinson’s – One Day at a Time

Finding Novel Strategies to Impact Everyday Life for People with Parkinson’s – One Day at a Time

by Elisa Pelosin, PhD

Clinical ScienceElisa Pelosin, PhDJanuary 4, 2021Parkinson's, Parkinson's Disease and Movement Disorder Society, six

Can We Treat Parkinson’s Disease by Suppressing the Immune System?

Can We Treat Parkinson’s Disease by Suppressing the Immune System?

by Caroline Williams-Gray, MRCP PhD

Clinical ScienceCaroline Williams-Gray MRCP PhDDecember 9, 2020Parkinson's, Immune System, five

Towards Deciphering Parkinsonism-Associated Pathogenesis

Towards Deciphering Parkinsonism-Associated Pathogenesis

by Coro Paisán-Ruiz, PhD

Clinical ScienceCoro Paisán-Ruiz, PhDNovember 16, 2020Parkinson's, Genetics, five

Beyond Clinic: How Can Imaging Help in the Diagnosis of Parkinson´s Disease?

Beyond Clinic: How Can Imaging Help in the Diagnosis of Parkinson´s Disease?

by Cecilia Peralta, PhD

Clinical ScienceCecilia Peralta, MDNovember 9, 2020Parkinson's, Imaging, Diagnosis, five